DHCPL – Instruction for use for Sybrava Inclisiran single-dose pre-filled syringe

DHCPL – Instruction for use for Sybrava Inclisiran single-dose pre-filled syringe

This DHCP letter is initiated by Norvatis and is intended to inform healthcare professionals about important new user handling instructions for the Sybrava® (inclisiran) single-dose pre-filled syringe injection, to reduce the risks associated with administration of the product.

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 31/05/2024
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance